We have all heard this, or some variation of it:
JHU, MGH, BWH, UCSF, Duke, and UPenn are top tier or Tier 1a
UMich, WashU, UWash, Mayo and Columbia are middle-top tier or Tier 1b
UAB, Vandy, Cornell, UTSW, BIDMC, UNC, and UCLA are bottom-top tier or T1c
I know this categorization is in no doubt strongly based on the USNWR "best hopitals/medical school" list, and also on the caliber of the fellowship placements of IM grads from these institutes (placements that are in turn also considered "solid" based on the USNWR data). My questions are about the truth behind these rankings:
(1)Imagine three individuals with an identical potential for becoming outstanding clinicians:
(a) Would there be significant difference in their clinical acumen at the end of residency if they individually went to UCSF vs WashU vs UTSW, or Duke vs Columbia vs BIDMC?
(b) If these three individuals are very driven and proactive in seeking out research, do Tier-1a institutes always offer better opportunities that T1-b/c?
(2) Are there certain teaching philosophies that contribute to where programs rank in these tiers (e.g. JHU is known for its autonomy, Duke is known for its EBMcentric curriculum)?
(3) Are these classifications too elitist and outdated as there are numerous solid IM training programs that are unheard of due their location or status as community programs?
Of interest: http://www.brimr.org/NIH_Awards/2008/NIH_Awards_2008.htm
JHU, MGH, BWH, UCSF, Duke, and UPenn are top tier or Tier 1a
UMich, WashU, UWash, Mayo and Columbia are middle-top tier or Tier 1b
UAB, Vandy, Cornell, UTSW, BIDMC, UNC, and UCLA are bottom-top tier or T1c
I know this categorization is in no doubt strongly based on the USNWR "best hopitals/medical school" list, and also on the caliber of the fellowship placements of IM grads from these institutes (placements that are in turn also considered "solid" based on the USNWR data). My questions are about the truth behind these rankings:
(1)Imagine three individuals with an identical potential for becoming outstanding clinicians:
(a) Would there be significant difference in their clinical acumen at the end of residency if they individually went to UCSF vs WashU vs UTSW, or Duke vs Columbia vs BIDMC?
(b) If these three individuals are very driven and proactive in seeking out research, do Tier-1a institutes always offer better opportunities that T1-b/c?
(2) Are there certain teaching philosophies that contribute to where programs rank in these tiers (e.g. JHU is known for its autonomy, Duke is known for its EBMcentric curriculum)?
(3) Are these classifications too elitist and outdated as there are numerous solid IM training programs that are unheard of due their location or status as community programs?
Of interest: http://www.brimr.org/NIH_Awards/2008/NIH_Awards_2008.htm